William Sandborn
MD
Professor of Medicine (Emeritus)
👥Biography 个人简介
William Sandborn is one of the most prolific IBD clinical trialists in history and helped develop virtually every modern IBD biologic including infliximab, adalimumab, vedolizumab, and ozanimod. His work established long-term safety profiles including malignancy monitoring that informs IBD cancer risk assessment. He has mentored many current IBD leaders.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 William Sandborn 的研究动态
Follow William Sandborn's research updates
留下邮箱，当我们发布与 William Sandborn（University of California San Diego）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment